Have a personal or library account? Click to login
Efficacy of nucleoside analogues for hepatitis B virus-related liver failure: A network meta-analysis Cover

Efficacy of nucleoside analogues for hepatitis B virus-related liver failure: A network meta-analysis

Acta Pharmaceutica
Volume 68 (2018): Issue 1 (March 2018)
By:
Open Access
|Feb 2018

References

  1. 1. Y. Zhijian, L. Hui, Y. Weiming, L. Zhanzhou, C. Zhong, Z. Jinxin, W. Hongyan, D. Xiangbin, Y. Weizhi, L. Duoyun, L. Xiaojun and D. Qiwen, Role of the aspartate transaminase and platelet ratio index in assessing hepatic fibrosis and liver inflammation in adolescent patients with HBeAg-positive chronic hepatitis B, Gastroenterol. Res. Pract. 2015 (2015) Article ID 906026 (6 pages); <a href="https://doi.org/10.1155/2015/906026" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1155/2015/906026</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1155/2015/906026" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1155/2015/906026</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmcid">4506824</dgpm:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">26236336</dgpm:pub-id>
    Search in Google ScholarBack to article
  2. 2. Q. Zhou and H. Tang, The progress of antiviral therapy in patients with HBV-related liver failure, Hepatogastroenterology 60 (2013) 1877-1880.
    Search in Google ScholarBack to article
  3. 3. S. Locarnini, Molecular virology of hepatitis B virus, Semin. Liver Dis. 24 (Suppl 1) (2004) 3-10.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1055/s-2004-828672" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1055/s-2004-828672</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">15192795</dgpm:pub-id>
    Search in Google ScholarBack to article
  4. 4. Y. F. Liaw, Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy, Antivir. Ther. 11 (2006) 669-679.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1177/135965350601100614" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1177/135965350601100614</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  5. 5. Y. N. Ye and Z. L. Gao, Three attacks in the development of HBV-related liver failure, Infect. Dis. Inf. 22 (2009) 276-279; <a href="https://doi.org/10.3969/j.issn.1007-8134.2009.05.006" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3969/j.issn.1007-8134.2009.05.006</a>
    Search in Google ScholarBack to article
  6. 6. S. Uemoto, Y. Inomata, T. H. Egawa, S. Fujita, T. Kiuchi, M. Hayashi, M. Yasutomi, H. Yamabe and K. Tanaka, Living donor liver transplantation for fulminant hepatic failure, Transplant. Proc. 42 (2010) 990-993; <a href="https://doi.org/10.18926/AMO/55435" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.18926/AMO/55435</a>
    Search in Google ScholarBack to article
  7. 7. J. Gu, X. Shi, H. Ren, Q. Xu and J. Wang, Systematic review: extracorporeal bio-artificial liversupport system for liver failure, Hepatol. Int. 6 (2012) 670-683; <a href="https://doi.org/10.1007/s12072-012-9352-9" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1007/s12072-012-9352-9</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1007/s12072-012-9352-9" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s12072-012-9352-9</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">26201519</dgpm:pub-id>
    Search in Google ScholarBack to article
  8. 8. M. K. Jain, L. Comanor, C. White, P. Kipnis, C. Elkin, K. Leung, A. Ocampo, N. Attar, P. Keiser and W. M. Lee, Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response, J. Viral Hepatitis 14 (2007) 176-182; <a href="https://doi.org/10.1111/j.1365-2893.2006.00797.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1111/j.1365-2893.2006.00797.x</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1365-2893.2006.00797.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1365-2893.2006.00797.x</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">17305883</dgpm:pub-id>
    Search in Google ScholarBack to article
  9. 9. Y. W. Kim, J. H. Kwon, E. Chung, S. W. Lee, J.-y. Lee, J. W. Jang, K. W. Chung and S. W. Nam, Short term virologic efficacies of telbivudine versus entecavir against hepatitis B-related hepatocellular carcinoma, Gastroenterol. Res. Pract. 2015 (2015) Article ID 181065 (7 pages); <a href="https://doi.org/10.1155/2015/181065" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1155/2015/181065</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1155/2015/181065" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1155/2015/181065</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmcid">4387973</dgpm:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">25878659</dgpm:pub-id>
    Search in Google ScholarBack to article
  10. 10. J. F. Zhang, Y. Guo, C. X. Chen, H. Y. Song, J. Dong, X. Chen, Z. L. Chen and B. Liu, A study on the treatment effect of telbivudine on hepatitis B patients with acute on chronic liver failure, Mil. Med. J. Southeast China (2016); <a href="https://doi.org/10.3760/cma.j.issn.1007-3418.2015.01.006" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3760/cma.j.issn.1007-3418.2015.01.006</a>
    Search in Google ScholarBack to article
  11. 11. S. S. Ma, Effect of enticavir on survival of patients with HBV-related liver failure: A meta-analysis, Shi Jie Hua Ren Xiao Hua Za Zhi (World Chin. J. Digestol.) 21 (2013) 2594-2600.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.11569/wcjd.v21.i25.2594" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.11569/wcjd.v21.i25.2594</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  12. 12. B. Hutton, G. Salanti, D. M. Caldwell, A. Chaimani, C. H. Schmid, C. Cameron, J. P. A. Ioannidis, S. Straus, K. Thorlund, J. P. Jansen, C. Mulrow, F. Catalá-López, P. C. Gøtzsche, K. Dickersin, I. Boutron, D. G. Altman and D. Moher, The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations, Ann. Intern. Med. 162 (2015) 777-784; <a href="https://doi.org/10.7326/m14-2385" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.7326/m14-2385</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.7326/M14-2385" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.7326/M14-2385</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">26030634</dgpm:pub-id>
    Search in Google ScholarBack to article
  13. 13. C. P. Robert and G. Casella, Monte Carlo Statistical Methods, 2nd ed., Springer, New York, 2004.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1007/978-1-4757-4145-2" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/978-1-4757-4145-2</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  14. 14. S. P. Brooks and A. Gelman, General methods for monitoring convergence of iterative simulations, J. Comput. Graph. Stat. 7 (1998) 434-455.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1080/10618600.1998.10474787" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1080/10618600.1998.10474787</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  15. 15. T. Kanda, M. Shinozaki, H. Kamezaki, S. Wu, S. Nakamoto, M. Arai, K. Fujiwara, N. Goto, F. Imazeki and O. Yokosuka, Efficacy of lamivudine or entecavir on acute exacerbation of chronic hepatitis B, Int. J. Med. Sci. 9 (2012) 27-32.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.7150/ijms.9.27" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.7150/ijms.9.27</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmcid">3222087</dgpm:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">22211086</dgpm:pub-id>
    Search in Google ScholarBack to article
  16. 16. B. Lin, C. Q. Pan, D. Xie, J. Xie, S. Xie, X. Zhang, B. Wu, C. Lin and Z. Gao, Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B, Hepatol. Int. 7 (2013) 460-467; <a href="https://doi.org/10.1007/s12072-012-9415-y" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1007/s12072-012-9415-y</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1007/s12072-012-9415-y" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s12072-012-9415-y</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">26201778</dgpm:pub-id>
    Search in Google ScholarBack to article
  17. 17. L. J. Sun, J. W. Yu, Y. H. Zhao, P. Kang and S. C. Li, Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure, J. Gastroenterol. Hepatol. 25 (2010) 583-590; <a href="https://doi.org/10.1111/j.1440-1746.2009.06089.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1111/j.1440-1746.2009.06089.x</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1111/j.1440-1746.2009.06089.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1440-1746.2009.06089.x</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  18. 18. L. Wang, H. Chen, C. Fan and Z. Gong, Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection, J. Med. Virol. 85 (2013) 1907-1912; <a href="https://doi.org/10.1002/jmv.23689" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1002/jmv.23689</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1002/jmv.23689" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/jmv.23689</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  19. 19. Y. Xianghui, X. Lang, Z. Yan, Z. Li, S. Xiaofeng and R. Hong, Prediction of prognosis to lamivudine in patients with spontaneous reactivation of hepatitis B virus-related acute-on-chronic liver failure: Using virologic response at week 4, Eur. J. Intern. Med. 25 ( 2014) 8 60-864; <a href="https://doi.org/10.1016/j.ejim.2014.10.007" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.ejim.2014.10.007</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/j.ejim.2014.10.007" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ejim.2014.10.007</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  20. 20. T. Chen, Y. He, X. Liu, Z. Yan, K. Wang, H. Liu, S. Zhang and Y. Zhao, Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-onchronic liver failure, Clin. Exp. Med. 12 (2012) 159-164; <a href="https://doi.org/10.1007/s10238-011-0160-7" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1007/s10238-011-0160-7</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1007/s10238-011-0160-7" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s10238-011-0160-7</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  21. 21. Y. L. Cui, Y. Fang, Y. B. Wang, X. Q. Song, L. Li, X. Z. Lei, M. H. Zheng, T. Hong and F. Ping, Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection- associated acute or chronic liver failure, Dig. Dis. Sci. 55 ( 2010) 2 373-2380; <a href="https://doi.org/10.1007/s10620-010-1257-7" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1007/s10620-010-1257-7</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1007/s10620-010-1257-7" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s10620-010-1257-7</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  22. 22. H. Garg, S. K. Sarin, M. Kumar, V. Garg, B. C. Sharma and A. Kumar, Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure, Hepatology 53 (2011) 774-780; <a href="https://doi.org/10.1002/hep.24109" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1002/hep.24109</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1002/hep.24109" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/hep.24109</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  23. 23. K. Ma, W. Guo, M. Han, G. Chen, T. Chen, Z. Wu, D. Yang, J. Huang, Y. Huang, X. Zhao, J. Song, J. Qi and Q. Ning, Entecavir treatment prevents disease progression in HBV related acute-onchronic liver failure: Establishment of a novel logistical regression model, The International Liver Congress™ 201 - 46th annual meeting of the European Association for the Study of the Liver, Berlin, March 30 to April 3, 2011, Poster 742, J. Hepatol. 54 (Suppl. 1) (2011) S298; <a href="https://doi.org/10.1016/S0168-8278(11)60744-7" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/S0168-8278(11)60744-7</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/S0168-8278(11)60744-7" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S0168-8278(11)60744-7</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  24. 24. J. Lai, Y. Yan, L. Mai, Y. B. Zheng, W. Q. Gan and W. M. Ke, Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure, Hepatob. Pancreat. Dis. Int. 12 (2013) 154-159.<dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1016/S1499-3872(13)60025-9" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S1499-3872(13)60025-9</a></dgdoi:pub-id>
    Search in Google ScholarBack to article
  25. 25. Y. Zhang, X. Y. Hu, S. Zhong, F. Yang, T. Y. Zhou, G. Chen, Y. Y. Wang and J. X. Luo, Entecavir vs lamivudine therapy for naïve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure, World J. Gastroenterol. 20 (2014) 4745-4752; <a href="https://doi.org/10.3748/wjg.v20.i16.4745" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3748/wjg.v20.i16.4745</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.3748/wjg.v20.i16.4745" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3748/wjg.v20.i16.4745</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmcid">4000512</dgpm:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">24782628</dgpm:pub-id>
    Search in Google ScholarBack to article
  26. 26. J. Wang, K. Ma, M. Han, W. Guo, J. Huang, D. Yang, X. Zhao, J. Song, D. Tian and J. Qi, Nucleoside analogs prevent disease progression in HBV-related acute-on-chronic liver failure: validation of the TPPM model, Hepatol. Int. 8 (2014) 64-71; <a href="https://doi.org/10.1007/s12072-013-9485-5" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1007/s12072-013-9485-5</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1007/s12072-013-9485-5" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s12072-013-9485-5</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">26202407</dgpm:pub-id>
    Search in Google ScholarBack to article
  27. 27. J. Wang, J. Liu, C. Qi, T. Yan, F. Cao, L. Jin, Y. He, Y. Yang, S. Zhang, T. Chen and Y. Zhao, Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudineresistant HBV, Antivir. Ther. 20 (2015) 681-687; <a href="https://doi.org/10.3851/IMP2981" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3851/IMP2981</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.3851/IMP2981" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3851/IMP2981</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">26215771</dgpm:pub-id>
    Search in Google ScholarBack to article
  28. 28. B. Ceylan, C. Yardimci, M. Fincanci, G. Eren, U. Tozalgan, C. Muderrisoglu and Y. Akkoyunlu, Comparison of tenofovir and entecavir in patients with chronic HBV infection, Eur. Rev. Med. Pharmacol. Sci. 17 (2013) 2467-2473.
    Search in Google ScholarBack to article
  29. 29. Y. B. Lee, E. U. Jung, B. H. Kim, J. H. Lee, H. Cho, H. Ahn, W. M. Choi, Y. Y. Cho, M. Lee and J. J. Yoo, Tenofovir monotherapy versus tenofovir plus lamivudine or telbivudine combination therapy in treatment of lamivudine-resistant chronic hepatitis B, Antimicrob. Agents Ch. 59 (2014) 972-978; <a href="https://doi.org/10.1128/AAC.04454-14" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1128/AAC.04454-14</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1128/AAC.04454-14" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1128/AAC.04454-14</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmcid">4335865</dgpm:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">25421484</dgpm:pub-id>
    Search in Google ScholarBack to article
  30. 30. Z. Krastev, D. Petrova, I. Kotzev, M. K. Celen, M. Mendelson, R. Chandra, P. Pandey and K. Hamed, Telbivudine vs tenofovir in hepatitis B e antigen-negative chronic hepatitis B patients: OPTIMA roadmap study, World J. Hepatol. 8 (2016) 1402-1413; <a href="https://doi.org/10.4254/wjh.v8.i32.1402" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.4254/wjh.v8.i32.1402</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.4254/wjh.v8.i32.1402" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.4254/wjh.v8.i32.1402</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmcid">5114476</dgpm:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">27917266</dgpm:pub-id>
    Search in Google ScholarBack to article
  31. 31. P. Marcellin, Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B, New Engl. J. Med. 359 (2009) 2442-2455; <a href="https://doi.org/10.1056/NEJMoa0802878" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1056/NEJMoa0802878</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1056/NEJMoa0802878" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1056/NEJMoa0802878</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">19052126</dgpm:pub-id>
    Search in Google ScholarBack to article
  32. 32. V. Ratziu, V. Thibault, Y. Benhamou and T. Poynard, Successful rescue therapy with tenofovir in a patient with hepatic decompensation andesistant HBV mutant, Comp. Hepatol. 5 ( 2006) 1-4; <a href="https://doi.org/10.1186/1476-5926-5-1" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1186/1476-5926-5-1</a><dgdoi:pub-id xmlns:dgdoi="http://degruyter.com/resources/doi-from-crossref" pub-id-type="doi"><a href="https://doi.org/10.1186/1476-5926-5-1" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1186/1476-5926-5-1</a></dgdoi:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmcid">1363728</dgpm:pub-id><dgpm:pub-id xmlns:dgpm="http://degruyter.com/resources/fetched-pubmed-id" pub-id-type="pmid">16405720</dgpm:pub-id>
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/acph-2018-0010 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 19 - 30
Accepted on: Dec 4, 2017
Published on: Feb 16, 2018
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
liver failure,
hepatitis B virus,
nucleoside analogue,
tenofovir,
network meta-analysis
Related subjects:
Pharmacy,
Pharmacy, other

© 2018 Jian Wu, Fang Yin, Xinmin Zhou, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 68 (2018): Issue 1 (March 2018)Next article